Homozygous deletion of mouse homolog of p16/CDKN2 gene on chromosome 4 in mouse liver epithelial cells in culture

被引:0
|
作者
Miyasaka, K [1 ]
Kawauchi, S [1 ]
机构
[1] HOSHI UNIV, DEPT HYG CHEM, SHINAGAWA KU, TOKYO 142, JAPAN
关键词
mouse homolog; p16/CDKN2; immortalization; microsatellite; tumor suppressor gene;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The culture of hepatocytes isolated from C3H mouse liver results in the spontaneous development of colonies of liver epithelial cells that possess some features of the hepatocytes. These liver epithelial cells frequently have a loss of chromosome 4, and become neoplasms which are hepatocellular carcinomas by transfection with the activated c-Ha-ras gene, The suppression of malignant phenotypes by mouse chromosome 4 has already been shown by fusion between normal and malignant mouse cells, We established a total of six liver epithelial cell lines from C3H mice in order to investigate the presence of a tumor suppressor gene(s) on chromosome 4 in mouse hepatocarcinogenesis, and performed an allelotype analysis in seven microsatellites on chromosome 4 by the comparative multiplex PCR method. The result of analysis revealed that three of the six liver epithelial cells had allelic imbalances in four microsatellite loci, especially, two liver epithelial cell lines showed homozygous deletion in the D4MIT177 locus. Then, we investigated the status of the mouse homolog of p16/CDKN2 gene (mouse p16) on chromosome 4 by the comparative multiplex PCR method, and detected the homozygous deletion in two liver epithelial cell lines. Our result thus supports the theory that alterations of tumor suppressor gene(s) located on chromosome 4 may play a role in mouse hepatocarcinogenesis. Mouse p16, which is an inhibitor of cyclin dependent kinase 4, may suppress the cancer development in mouse hepatocarcinogenesis, or suppress liver cell immortalization.
引用
收藏
页码:345 / 349
页数:5
相关论文
共 50 条
  • [21] Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma
    Gonzalez, MV
    Pello, MF
    LopezLarrea, C
    Suarez, C
    Menendez, MJ
    Coto, E
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (06) : 509 - 512
  • [22] DNA hypomethylation and gene expression of p16/CDKN2 in breast carcinoma.
    Calvano, JE
    Bisogna, M
    VanZee, KJ
    [J]. FASEB JOURNAL, 1997, 11 (03): : 584 - 584
  • [23] Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices
    Ono, Y
    Tamiya, T
    Ichikawa, T
    Kunishio, K
    Matsumoto, K
    Furuta, T
    Ohmoto, T
    Ueki, K
    Louis, DN
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (10): : 1026 - 1031
  • [24] Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers
    Muzeau, F
    Flejou, JF
    Thomas, G
    Hamelin, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1997, 72 (01) : 27 - 30
  • [25] Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas
    Fueyo, J
    GomezManzano, C
    Bruner, JM
    Saito, Y
    Zhang, BH
    Zhang, W
    Levin, VA
    Yung, WKA
    Kyritsis, AP
    [J]. ONCOGENE, 1996, 13 (08) : 1615 - 1619
  • [26] P16 (CDKN2) IS A MAJOR DELETION TARGET AT 9P21 IN BLADDER-CANCER
    WILLIAMSON, MP
    ELDER, PA
    SHAW, ME
    DEVLIN, J
    KNOWLES, MA
    [J]. HUMAN MOLECULAR GENETICS, 1995, 4 (09) : 1569 - 1577
  • [27] p16(INK4A)/MTS1/CDKN2 - The melanoma gene? [p16(INK4A)/MTS1/CDKN2 das'melanomgen'? Stand der forschung und ausblick]
    Bogenrieder T.
    Landthaler M.
    Stolz W.
    [J]. Der Hautarzt, 1998, 49 (2): : 91 - 100
  • [28] CDKN2 (MTS1/p16(INK4A)) gene alterations in hematological malignancies
    Uchida, T
    Kinoshita, T
    Saito, H
    Hotta, T
    [J]. LEUKEMIA & LYMPHOMA, 1997, 24 (5-6) : 449 - 461
  • [29] VIABILITY OF HOMOZYGOTES FOR A GERMLINE DELETION OF 19 BP IN THE CODING REGION OF THE CDKN2/P16 GENE IN DUTCH MELANOMA FAMILIES
    FRANTS, RR
    VANDERVELDEN, PA
    SANDKUIJL, LA
    PRINS, DE
    BERGMAN, W
    GRUIS, NA
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 338 - 338
  • [30] CLINICOPATHOLOGICAL FEATURES AND PROGNOSTIC VALUE OF P16 (CDKN2) GENE DELETION AMONG PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
    Avagyan, Anna
    Ivanyan, Arusyak
    Tamamyan, Gevorg
    Vagharshakyan, Lala
    Petrosyan, Mery
    Hovhannisyan, Anna
    Anastasiadi, Medea
    Krmoyan, Lusine
    Gazaryan, Narine
    [J]. PEDIATRIC BLOOD & CANCER, 2022, 69